ArticleOncology and therapy2022

Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study.

Scott Paulson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.